Clinical trial · Interventional
SAS in Patients With Bronchial Carcinoma
Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma
NCT02270853CI-TRIAL-00020975SAS CAunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bronchial Carcinoma | Bronchogenic Carcinoma | ALIAS | 0.90 |
| Sleep Apnea Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| sleep apnea screening with ApneaLinkTM | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- sleep apnea screening with ApneaLinkTM
- description
- This is the only group in the present study. Patients with bronchial carcinoma (or reasonable suspicion) perform sleep screening with ApneaLinkTM at home or during the hospitalization.
- interventionNames
- Device: sleep apnea screening with ApneaLinkTM
Primary outcomes (1)
- measure
- percent of sleep apnea in patients with bronchial carcinoma
- timeFrame
- two days
- description
- The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and * Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma. Exclusion Criteria: * Pregnancy * other already known malignancies or tumors * Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies
References
Publications (1)
- DERIVEDDreher M, Kruger S, Schulze-Olden S, Keszei A, Storre JH, Woehrle H, Arzt M, Muller T. Sleep-disordered breathing in patients with newly diagnosed lung cancer. BMC Pulm Med. 2018 May 16;18(1):72. doi: 10.1186/s12890-018-0645-1. PMID 29769049